The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Head-to-head comparison of the dual-MEK inhibitor IMM-1-104 versus sotorasib or adagrasib in KRAS mutant pancreatic tumors.

Peter J.  King

Employment - Immuneering

Stock and Other Ownership Interests  - Immuneering

Matthew  Nord

Employment - Immuneering

Stock and Other Ownership Interests  - Immuneering

Anna  Travesa

Employment - Immuneering

Stock and Other Ownership Interests  - Immuneering

Amy  Axel

Employment - Immuneering

Stock and Other Ownership Interests  - Immuneering

Sarah  Kolitz

Employment - Immuneering

Stock and Other Ownership Interests  - Immuneering

Jason  Funt

Employment - Immuneering

Stock and Other Ownership Interests  - Immuneering

Kevin  Fowler

Employment - Immuneering

Stock and Other Ownership Interests  - Immuneering

Biren  Amin

Employment - Immuneering

Leadership - Immuneering

Stock and Other Ownership Interests  - Immuneering

Praveen  Nair

Employment - Immuneering

Stock and Other Ownership Interests  - Immuneering

Scott  Barrett

Employment - Immuneering

Leadership - Immuneering

Stock and Other Ownership Interests  - Immuneering

Benjamin  Zeskind

Employment - Immuneering

Leadership - Immuneering

Stock and Other Ownership Interests  - Immuneering

Brett  Hall

Employment - Immuneering

Leadership - Immuneering

Stock and Other Ownership Interests  - Immuneering